Literature DB >> 15811002

Is osseous dysplasia a primary feature of neurofibromatosis 1 (NF1)?

S Alwan1, S J Tredwell, J M Friedman.   

Abstract

Characteristic skeletal lesions are a cardinal feature of the autosomal dominant condition, neurofibromatosis 1 (NF1). The most frequently involved skeletal sites are the sphenoid wing, vertebrae, and tibia. Osseous lesions may range in severity in NF1 but are often progressive. They may lead to serious clinical consequences and be resistant to treatment. The skeletal lesions of NF1 are usually considered to be 'dysplasias', i.e. primary defects of bone, although there is no direct evidence supporting this interpretation. Moreover, it is difficult to understand why a generalized dysplasia of bone would produce focal lesions that show such a striking predisposition to only a few bones. We review the clinical and pathological features of NF1 skeletal lesions and propose that they result from an abnormal response of NF1 halpoinsufficient bone to abnormal mechanical forces rather than from a primary osseous dysplasia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15811002     DOI: 10.1111/j.1399-0004.2005.00410.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  20 in total

1.  Whole-body MRI in neurofibromatosis: incidental findings and prevalence of scoliosis.

Authors:  Jacob L Jaremko; Peter J MacMahon; Martin Torriani; Vanessa L Merker; Victor F Mautner; Scott R Plotkin; Miriam A Bredella
Journal:  Skeletal Radiol       Date:  2011-12-07       Impact factor: 2.199

2.  Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I.

Authors:  Weixi Wang; Jeffry S Nyman; Koichiro Ono; David A Stevenson; Xiangli Yang; Florent Elefteriou
Journal:  Hum Mol Genet       Date:  2011-07-14       Impact factor: 6.150

3.  ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae.

Authors:  Florent Elefteriou; M Douglas Benson; Hideaki Sowa; Michael Starbuck; Xiuyun Liu; David Ron; Luis F Parada; Gerard Karsenty
Journal:  Cell Metab       Date:  2006-12       Impact factor: 27.287

4.  Craniofacial bone alterations in patients with neurofibromatosis type 1.

Authors:  Julie Chauvel-Picard; Laurence Lion-Francois; Pierre-Aurélien Beuriat; Christian Paulus; Alexandru Szathmari; Carmine Mottolese; Arnaud Gleizal; Federico Di Rocco
Journal:  Childs Nerv Syst       Date:  2020-06-25       Impact factor: 1.475

5.  Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.

Authors:  Wei Zhang; Steven D Rhodes; Liming Zhao; Yongzheng He; Yingze Zhang; Yong Shen; Dalong Yang; Xiaohua Wu; Xiaohong Li; Xianlin Yang; Su-Jung Park; Shi Chen; Charles Turner; Feng-Chun Yang
Journal:  Bone       Date:  2011-03-23       Impact factor: 4.398

6.  Height assessments in children with neurofibromatosis type 1.

Authors:  Elizabeth A Soucy; Dorothy van Oppen; Nicole L Nejedly; Feng Gao; David H Gutmann; Abby S Hollander
Journal:  J Child Neurol       Date:  2012-06-29       Impact factor: 1.987

7.  Effects of resveratrol on the proliferation and osteogenic differentiation of deciduous dental pulp stem cells from neurofibromatosis type 1 patient.

Authors:  Claudinéia Pereira Maranduba; Gustavo Torres Souza; Antônio Márcio Resende do Carmo; José Marcelo Sallabert de Campos; Nádia Rezende Barbosa Raposo; Marcelo de Olivera Santos; Carlos Magno da Costa Maranduba; Fernando de Sá Silva
Journal:  Childs Nerv Syst       Date:  2020-11-20       Impact factor: 1.475

Review 8.  Aberrant Myeloid Differentiation Contributes to the Development of Osteoporosis in Neurofibromatosis Type 1.

Authors:  Steven D Rhodes; Feng-Chun Yang
Journal:  Curr Osteoporos Rep       Date:  2016-02       Impact factor: 5.096

9.  Neuroimaging findings of extensive sphenoethmoidal dysplasia in NF1.

Authors:  Allison Tam; Joseph M Sliepka; Sunil Bellur; Collin Douglas Bray; Christie M Lincoln; Sandesh C S Nagamani
Journal:  Clin Imaging       Date:  2018-05-16       Impact factor: 1.605

10.  Generalized metabolic bone disease in Neurofibromatosis type I.

Authors:  Nicola Brunetti-Pierri; Stephen B Doty; John Hicks; Kelly Phan; Roberto Mendoza-Londono; Maria Blazo; Alyssa Tran; Susan Carter; Richard Alan Lewis; Sharon E Plon; William A Phillips; E O'Brian Smith; Kenneth J Ellis; Brendan Lee
Journal:  Mol Genet Metab       Date:  2008-03-04       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.